The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Glomerular Localization and Expression of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme: Implications for Albuminuria in Diabetes
Abstract
Angiotensin-converting enzyme 2 (ACE2) expression has been shown to be altered in renal tubules from diabetic mice. This study examined the localization of ACE and ACE2 within the glomerulus of kidneys from control (db/m) and diabetic (db/db) mice and the effect of chronic pharmacologic ACE2 inhibition. ACE2 co-localized with glomerular epithelial cell (podocyte) markers, and its localization within the podocyte was confirmed by immunogold labeling. ACE, by contrast, was seen only in glomerular endothelial cells. By immunohistochemistry, in glomeruli from db/db mice, strong ACE staining was found more frequently than in control mice (db/db 64.6 +/- 6.3 versus db/m 17.8 +/- 3.4%; P < 0.005). By contrast, strong ACE2 staining in glomeruli from diabetic mice was less frequently seen than in controls (db/db 4.3 +/- 2.4 versus db/m 30.6 +/- 13.6%; P < 0.05). For investigation of the significance of reduced glomerular ACE2 expression, db/db mice were treated for 16 wk with a specific ACE2 inhibitor (MLN-4760) alone or combined with telmisartan, a specific angiotensin II type 1 receptor blocker. At the end of the study, glomerular staining for fibronectin, an extracellular matrix protein, was increased in both db/db and db/m mice that were treated with MLN-4760. Urinary albumin excretion (UAE) increased significantly in MLN-4760-treated as compared with vehicle-treated db/db mice (743 +/- 200 versus 247 +/- 53.9 microg albumin/mg creatinine, respectively; P < 0.05), and the concomitant administration of telmisartan completely prevented the increase in UAE associated with the ACE2 inhibitor (161 +/- 56; P < 0.05). It is concluded that ACE2 is localized in the podocyte and that in db/db mice glomerular expression of ACE2 is reduced whereas glomerular ACE expression is increased. The finding that chronic ACE2 inhibition increases UAE suggests that ACE2, likely by modulating the levels of glomerular angiotensin II via its degradation, may be a target for therapeutic interventions that aim to reduce albuminuria and glomerular injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Towler, P., Staker, B., Prasad, S. G., Menon, S., Tang, J., Parsons, T., Ryan, D., Fisher, M., Williams, D., Dales, N. A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311191200 · Cited by 696
From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease
Wolf, G., Chen, S., & Ziyadeh, F. N. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1626 · Cited by 565
Diabetic kidney disease in the db/db mouse
Sharma, K., McCue, P., & Dunn, S. R. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00315.2002 · Cited by 521
Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat.
Seikaly, M. G., Arant, B. S., & Seney, F. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114846 · Cited by 425
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Burrell, L. M., Risvanis, J., & Cooper, M. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000060689.38912.cb · Cited by 350
Podocin Localizes in the Kidney to the Slit Diaphragm Area
Roselli, S., Gribouval, O., Boute, N., Sich, M., Benessy, F., Attié, T., Gubler, M.-C., & Antignac, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64357-x · Cited by 341
ACE and ACE2 Activity in Diabetic Mice
Wysocki, J., Ye, M., Soler, M. J., Gurley, S. B., Xiao, H. D., Bernstein, K. E., Coffman, T. M., Chen, S., & Batlle, D. (2006) · Diabetes · doi:10.2337/db06-0033 · Cited by 339
Self-citationDurvasula, R. V., Petermann, A. T., Hiromura, K., Blonski, M., Pippin, J., Mundel, P., Pichler, R., Griffin, S., Couser, W. G., & Shankland, S. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00362.x · Cited by 313
Anderson, S., Jung, F. F., & Ingelfinger, J. R. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.265.4.f477 · Cited by 307
Impact of genetic background on nephropathy in diabetic mice
Gurley, S. B., Clare, S. E., Snow, K. P., Hu, A., Meyer, T. W., & Coffman, T. M. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00204.2005 · Cited by 286
Angiotensin-I-converting enzyme and its relatives.
Riordan, J. F. (2003) · Genome biology · doi:10.1186/gb-2003-4-8-225 · Cited by 272
Remuzzi, A., Puntorieri, S., Battaglia, C., Bertani, T., & Remuzzi, G. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114470 · Cited by 259
Eremina, V., Cui, S., Gerber, H., Ferrara, N., Haigh, J., Nagy, A., Ema, M., Rossant, J., Jothy, S., Miner, J. H., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080810 · Cited by 246
Renal ACE2 expression in human kidney disease
Lely, A., Hamming, I., van Goor, H., & Navis, G. (2004) · The Journal of Pathology · doi:10.1002/path.1670 · Cited by 239
Oudit, G. Y., Herzenberg, A. M., Kassiri, Z., Wong, D., Reich, H., Khokha, R., Crackower, M. A., Backx, P. H., Penninger, J. M., & Scholey, J. W. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051091 · Cited by 232
Vascular gp91 phox : Beyond the Endothelium
Pagano, P. J. (2000) · Circulation Research · doi:10.1161/01.res.87.1.1 · Cited by 229
Ye, M., Wysocki, J., Naaz, P., Salabat, M. R., LaPointe, M. S., & Batlle, D. (2004) · Hypertension · doi:10.1161/01.hyp.0000126192.27644.76 · Cited by 221
Self-citationAngiotensin-(1–7) Reduces Smooth Muscle Growth After Vascular Injury
Strawn, W. B., Ferrario, C. M., & Tallant, E. A. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.207 · Cited by 184
Thomas, P. E., Wharram, B. L., Goyal, M., Wiggins, J. E., Holzman, L. B., & Wiggins, R. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32113-0 · Cited by 162
Huang, W., Gallois, Y., Bouby, N., Bruneval, P., Heudes, D., Belair, M., Krege, J. H., Meneton, P., Marre, M., Smithies, O., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231476798 · Cited by 151
Li, N., Zimpelmann, J., Cheng, K., Wilkins, J. A., & Burns, K. D. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00144.2004 · Cited by 143
Macconi, D., Ghilardi, M., Bonassi, M. E., Mohamed, E. I., Abbate, M., Colombi, F., Remuzzi, G., & Remuzzi, A. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v113477 · Cited by 134
Gene expression of the renin-angiotensin system in human kidney
Lai, K. N., Leung, J. C. K., Lai, K. B., To, W. Y., Yeung, V. T. F., & Lai, F. M. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816010-00014 · Cited by 114
Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney.
Łapiński, R., Perico, N., Remuzzi, A., Sangalli, F., Benigni, A., & Remuzzi, G. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v75653 · Cited by 113
Angiotensin II Increases Connective Tissue Growth Factor in the Kidney
Rupérez, M., Ruiz‐Ortega, M., Esteban, V., Lorenzo, Ó., Mezzano, S. A., Plaza, J. J. G., & Egido, J. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63552-3 · Cited by 112
Macconi, D., Abbate, M., Morigi, M., Angioletti, S., Mister, M., Buelli, S., Bonomelli, M., Mundel, P. H., Endlich, K., Remuzzi, A., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050701 · Cited by 98
Angiotensin-converting enzyme in non-neoplastic kidney diseases
Metzger, R. P., Bohle, R. M., Pauls, K., Eichner, G., Alhenc‐Gelas, F., Danilov, S. M., & Franke, F. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00660.x · Cited by 95
Development of vascular pole-associated glomerulosclerosis in the Fawn-hooded rat.
Kriz, W., Hosser, H., Hähnel, B., Simons, J. L., & Provoost, A. P. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v93381 · Cited by 89
Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species
Féliers, D., Gorin, Y. C., Ghosh-Choudhury, G., Abboud, H. E., & Kasinath, B. S. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00331.2005 · Cited by 77
Angiotensin-(1-7): a novel vasodilator of the coronary circulation.
Brosnihan, K. B., Li, P., Tallant, E. A., et al. (1998) · PubMed · Cited by 73
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Role of angiotensin II in glomerular injury
Ma, L., & Fogo, A. B. (2001) · Seminars in Nephrology · doi:10.1053/snep.2001.26793 · Cited by 51
Zhang, S., Marlier, A., Gribouval, O., Gilbert, T., Heidet, L., Antignac, C., & Gübler, M.-C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00840.x · Cited by 51
Féliers, D., Duraisamy, S., Barnes, J. L., Ghosh-Choudhury, G., & Kasinath, B. S. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00271.2004 · Cited by 48
Ingelfinger, J. R. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006090986 · Cited by 32
Cited by
Extrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
Ni, W., Yang, X., Yang, D., Bao, J., Li, R., Xiao, Y., Hou, C., Wang, H., Liu, J., Yang, D., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03120-0 · Cited by 1,175
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology
Batlle, D., Soler, M. J., Sparks, M. A., Hiremath, S., South, A. M., Welling, P. A., Swaminathan, S., & on behalf of the COVID-19 and ACE2 in Cardiovascular, L. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040419 · Cited by 614
Self-citationImmunity, endothelial injury and complement-induced coagulopathy in COVID-19
Perico, L., Benigni, A., Casiraghi, F., Ng, L. F. P., Renia, L., & Remuzzi, G. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00357-4 · Cited by 607
Sardu, C., Gambardella, J., Morelli, M. B., Wang, X., Marfella, R., & Santulli, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051417 · Cited by 592
Metadata
- Authors
- Ye, M., Wysocki, J., William, J., Soler, M. J., Cokic, I., & Batlle, D.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-11
- Volume
- 17
- Issue
- 11
- Pages
- 3067-3075
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2104899725
- Cited by
- 485
- References
- 40
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.